STT3A/B-IN-1, an orally active inhibitor of STT3A/B, exhibits antiviral properties and elevates the expression levels of the DERL3 gene. This compound holds promise for the study of viral diseases, including cancer and neurodegenerative disorders.
Molecular Weight:
355.45
Formula:
C19H21N3O2S
Target:
Others|||Virus Protease
* VAT and and shipping costs not included. Errors and price changes excepted
